3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors

Bioorg Med Chem Lett. 2012 Mar 1;22(5):1980-4. doi: 10.1016/j.bmcl.2012.01.031. Epub 2012 Jan 21.

Abstract

A series of 3,5-disubstituted indole derivatives was designed, synthesized and evaluated as inhibitors of human nitric oxide synthase (NOS). Various guanidine isosteric groups were explored at the 5-position of the indole ring, while keeping the basic amine side chain such as N-methylpiperidine ring, fixed at the 3-position of the indole ring. Compounds having 2-thiophene amidine and 2-furanyl amidine groups (7, 8, 10 and 12) showed increased activity for human neuronal NOS and good selectivity over endothelial and inducible NOS isoforms. Compound 8 was shown to reverse (10mg/kg, ip) thermal hyperalgesia in the L(5)/L(6) spinal nerve ligation (neuropathic pain) model and was devoid of any significant drug-drug interaction potential due to cytochrome P450 inhibition or cardiovascular liabilities associated with the inhibition of endothelial NOS.

MeSH terms

  • Animals
  • Cytochrome P-450 Enzyme Inhibitors
  • Cytochrome P-450 Enzyme System / metabolism
  • Humans
  • Hyperalgesia / drug therapy*
  • Indoles / chemical synthesis
  • Indoles / chemistry*
  • Indoles / pharmacology
  • Indoles / therapeutic use*
  • Migraine Disorders / drug therapy
  • Neuralgia / drug therapy*
  • Nitric Oxide Synthase Type I / antagonists & inhibitors*
  • Nitric Oxide Synthase Type I / metabolism
  • Nitric Oxide Synthase Type III / antagonists & inhibitors
  • Nitric Oxide Synthase Type III / metabolism
  • Rats
  • Spinal Nerves / drug effects*

Substances

  • Cytochrome P-450 Enzyme Inhibitors
  • Indoles
  • Cytochrome P-450 Enzyme System
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type III